A real world study assessing the impact of AJOVY in migraine patients with comorbid depression, anxiety or hypertension (HTN)
Latest Information Update: 10 Jun 2021
At a glance
- Drugs Fremanezumab (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 10 Jun 2021 New trial record
- 06 Jun 2021 Results presented at the 63rd Annual Scientific Meeting of the American Headache Society